loading
前日終値:
$230.59
開ける:
$230.87
24時間の取引高:
770.21K
Relative Volume:
0.84
時価総額:
$14.25B
収益:
$4.44B
当期純損益:
$29.49M
株価収益率:
-12,330.43
EPS:
-0.0184
ネットキャッシュフロー:
$1.19B
1週間 パフォーマンス:
-1.01%
1か月 パフォーマンス:
-0.83%
6か月 パフォーマンス:
+33.67%
1年 パフォーマンス:
+106.93%
1日の値動き範囲:
Value
$225.55
$231.78
1週間の範囲:
Value
$225.55
$236.71
52週間の値動き範囲:
Value
$105.00
$243.32

Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile

Name
名前
Jazz Pharmaceuticals Plc
Name
セクター
Healthcare (1107)
Name
電話
353-1-634-7800
Name
住所
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
Name
職員
2,890
Name
Twitter
@jazzpharma
Name
次回の収益日
2026-08-04
Name
最新のSEC提出書
Name
JAZZ's Discussions on Twitter

Compare JAZZ vs VRTX, REGN, ARGX, ALNY, RVMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
JAZZ icon
JAZZ
Jazz Pharmaceuticals Plc
226.88 14.49B 4.44B 29.49M 1.19B -0.0184
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
453.17 114.33B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
614.73 64.47B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
878.49 54.99B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
281.90 38.42B 4.29B 577.22M 641.34M 4.2086
RVMD icon
RVMD
Revolution Medicines Inc
156.58 34.03B 742.00K -1.37B -1.07B -7.0731

Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-04-10 再開されました Raymond James Outperform
2026-02-27 開始されました Barclays Overweight
2025-11-24 ダウングレード UBS Buy → Neutral
2025-07-15 開始されました Deutsche Bank Buy
2025-03-07 アップグレード UBS Neutral → Buy
2025-02-26 ダウングレード Cantor Fitzgerald Overweight → Neutral
2025-02-13 アップグレード Wells Fargo Equal Weight → Overweight
2024-12-12 アップグレード Morgan Stanley Equal-Weight → Overweight
2024-06-05 開始されました Goldman Buy
2024-01-03 開始されました Robert W. Baird Outperform
2023-11-27 ダウングレード UBS Buy → Neutral
2023-09-29 開始されました Raymond James Mkt Perform
2023-06-12 再開されました Wells Fargo Equal Weight
2022-12-09 アップグレード Goldman Neutral → Buy
2022-06-14 開始されました UBS Buy
2022-04-06 ダウングレード Goldman Buy → Neutral
2021-11-19 再開されました Goldman Buy
2021-10-07 再開されました Jefferies Buy
2021-10-05 開始されました Citigroup Buy
2021-09-23 開始されました Needham Buy
2021-05-19 再開されました JP Morgan Overweight
2021-04-07 再開されました RBC Capital Mkts Outperform
2021-02-05 繰り返されました H.C. Wainwright Buy
2021-02-03 アップグレード Piper Sandler Neutral → Overweight
2021-01-29 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-12-16 開始されました UBS Buy
2020-11-03 繰り返されました H.C. Wainwright Buy
2020-10-09 繰り返されました H.C. Wainwright Buy
2020-09-14 ダウングレード Goldman Neutral → Sell
2020-09-14 再開されました JP Morgan Overweight
2020-08-06 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-07-28 アップグレード Wolfe Research Peer Perform → Outperform
2020-07-23 アップグレード H.C. Wainwright Neutral → Buy
2020-04-06 開始されました Jefferies Buy
2020-03-12 アップグレード Bernstein Mkt Perform → Outperform
2020-01-08 開始されました Goldman Neutral
2019-08-21 ダウングレード Piper Jaffray Overweight → Neutral
2019-06-11 開始されました Barclays Overweight
2019-03-20 開始されました SunTrust Buy
2018-12-14 開始されました Wolfe Research Peer Perform
2018-11-08 繰り返されました B. Riley FBR Buy
2018-08-08 繰り返されました Stifel Buy
2018-07-11 ダウングレード Morgan Stanley Overweight → Equal-Weight
2018-03-23 繰り返されました H.C. Wainwright Neutral
2018-03-19 アップグレード Morgan Stanley Equal-Weight → Overweight
すべてを表示

Jazz Pharmaceuticals Plc (JAZZ) 最新ニュース

pulisher
Jun 15, 2026

[144] Jazz Pharmaceuticals plc SEC Filing - Stock Titan

Jun 15, 2026
pulisher
Jun 15, 2026

JAZZ’s Zepzelca fails to meet primary goal in lung cancer study - MSN

Jun 15, 2026
pulisher
Jun 15, 2026

How Investors Are Reacting To Jazz (JAZZ) Zepzelca Failing Phase 3 LAGOON Survival Endpoint - simplywall.st

Jun 15, 2026
pulisher
Jun 15, 2026

JAZZ's Zepzelca Fails to Meet Primary Goal in Lung Cancer Study - Yahoo Finance

Jun 15, 2026
pulisher
Jun 15, 2026

Jazz Pharmaceuticals plc (JAZZ): Investor Outlook with Strong Buy Ratings and 11% Potential Upside - DirectorsTalk Interviews

Jun 15, 2026
pulisher
Jun 15, 2026

Jazz Pharma announces late-stage trial setback for lung cancer therapy - MSN

Jun 15, 2026
pulisher
Jun 14, 2026

Jazz, AstraZeneca, Astellas: Foreign healthcare's strongest quant picks - MSN

Jun 14, 2026
pulisher
Jun 12, 2026

Insider Sell: Neena Patil Sells Shares of Jazz Pharmaceuticals P - GuruFocus

Jun 12, 2026
pulisher
Jun 12, 2026

Jazz Pharmaceuticals (JAZZ) Shares Decline After Zepzelca Trial Results - GuruFocus

Jun 12, 2026
pulisher
Jun 12, 2026

[Form 4] Jazz Pharmaceuticals plc Insider Trading Activity - Stock Titan

Jun 12, 2026
pulisher
Jun 12, 2026

Jazz Pharmaceuticals lung cancer drug fails late-stage trial By Investing.com - Investing.com Nigeria

Jun 12, 2026
pulisher
Jun 12, 2026

Jazz Pharmaceuticals (JAZZ) Reports Phase 3 Trial Results for Ze - GuruFocus

Jun 12, 2026
pulisher
Jun 12, 2026

Jazz Pharmaceuticals' Zepzelca misses primary goal in Phase 3 LAGOON trial - grafa.com

Jun 12, 2026
pulisher
Jun 12, 2026

Jazz Pharmaceuticals lung cancer drug fails main trial goal - Reuters

Jun 12, 2026
pulisher
Jun 12, 2026

Jazz Pharmaceuticals stock falls after lung cancer trial fails By Investing.com - Investing.com Australia

Jun 12, 2026
pulisher
Jun 12, 2026

Jazz Pharmaceuticals stock falls after lung cancer trial fails - Investing.com

Jun 12, 2026
pulisher
Jun 12, 2026

Jazz Pharmaceuticals’ Zepzelca fails phase 3 lung cancer trial By Investing.com - Investing.com Australia

Jun 12, 2026
pulisher
Jun 12, 2026

Jazz Pharmaceuticals’ Zepzelca fails phase 3 lung cancer trial - Investing.com

Jun 12, 2026
pulisher
Jun 12, 2026

Jazz Pharma's lung cancer drug fails late-stage trial - marketscreener.com

Jun 12, 2026
pulisher
Jun 12, 2026

Jazz Pharmaceuticals Provides Update on Zepzelca® (lurbinectedin) Phase 3 LAGOON Trial in Second-Line Small Cell Lung Cancer - PR Newswire

Jun 12, 2026
pulisher
Jun 12, 2026

MIdWestOne Financial Group Inc. Cuts Stock Position in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Jun 12, 2026
pulisher
Jun 12, 2026

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Jun 12, 2026
pulisher
Jun 11, 2026

UBS upgrades Jazz Pharmaceuticals (JAZZ) - MSN

Jun 11, 2026
pulisher
Jun 11, 2026

New Xywav Data And FDA Ruling Put Jazz Valuation In Focus - Yahoo Finance

Jun 11, 2026
pulisher
Jun 11, 2026

Daiwa Securities Group Inc. Has $1.46 Million Stock Holdings in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Jun 11, 2026
pulisher
Jun 11, 2026

Allianz Asset Management GmbH Boosts Stock Position in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Jun 11, 2026
pulisher
Jun 10, 2026

Jazz Pharmaceuticals' New Cancer Drug Drives $1.3 Billion Opportunity, Says Analyst - Benzinga

Jun 10, 2026
pulisher
Jun 10, 2026

JAZZ Maintained by B of A Securities -- Price Target Raised to $307 - GuruFocus

Jun 10, 2026
pulisher
Jun 10, 2026

Jazz Pharmaceuticals plc Stock 12‑Month Price Target Raised to $259.28, Implies 13% Upside - TradingView

Jun 10, 2026
pulisher
Jun 10, 2026

GW&K Investment Management LLC Sells 27,068 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Jun 10, 2026
pulisher
Jun 10, 2026

Analysts Offer Insights on Healthcare Companies: Verastem (VSTM), Jazz Pharmaceuticals (JAZZ) and Humana (HUM) - The Globe and Mail

Jun 10, 2026
pulisher
Jun 10, 2026

BofA raises Jazz Pharmaceuticals stock price target on Ziihera sales By Investing.com - Investing.com UK

Jun 10, 2026
pulisher
Jun 10, 2026

Jazz Pharmaceuticals PLC $JAZZ Shares Acquired by Franklin Resources Inc. - MarketBeat

Jun 10, 2026
pulisher
Jun 09, 2026

Bernstein SocGen reiterates Jazz Pharmaceuticals stock rating at Market Perform - Investing.com UK

Jun 09, 2026
pulisher
Jun 09, 2026

JAZZ PHARMACEUTICALS PLC (NASDAQ:JAZZ) Presents a Decent Value Opportunity with Strong Valuation and Growth Potential - ChartMill

Jun 09, 2026
pulisher
Jun 09, 2026

Truist assumes Jazz Pharmaceuticals stock with buy on oncology growth By Investing.com - Investing.com UK

Jun 09, 2026
pulisher
Jun 08, 2026

Jazz Pharmaceuticals plc ($JAZZ) President, CEO and Director 2025 Pay Revealed - Quiver Quantitative

Jun 08, 2026
pulisher
Jun 08, 2026

Jazz Pharmaceuticals (JAZZ) sets 2026 AGM on directors, pay and share issuance powers - Stock Titan

Jun 08, 2026
pulisher
Jun 08, 2026

These healthcare stocks have maintained strong buy ratings for months - MSN

Jun 08, 2026
pulisher
Jun 08, 2026

Jazz Pharmaceuticals PLC $JAZZ Shares Sold by Los Angeles Capital Management LLC - MarketBeat

Jun 08, 2026
pulisher
Jun 08, 2026

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: Navigating a 6.14% Potential Upside Amidst Robust Revenue Growth - DirectorsTalk Interviews

Jun 08, 2026
pulisher
Jun 08, 2026

Capital World Investors Has $453.32 Million Holdings in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Jun 08, 2026
pulisher
Jun 08, 2026

CenterBook Partners LP Buys New Shares in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Jun 08, 2026
pulisher
Jun 07, 2026

Assessing Jazz Pharmaceuticals (JAZZ) Valuation After Xywav And Ziihera Updates And Strong Quarterly Results - simplywall.st

Jun 07, 2026
pulisher
Jun 06, 2026

ETFs Investing in Jazz Pharmaceuticals Public Limited Company Stocks - TradingView

Jun 06, 2026
pulisher
Jun 06, 2026

Jazz Pharmaceuticals Public Limited Company Trade Ideas — XETR:J7Z - TradingView

Jun 06, 2026
pulisher
Jun 06, 2026

Bank of New York Mellon Corp Purchases 715,361 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Jun 06, 2026
pulisher
Jun 05, 2026

Jazz Pharmaceuticals (NASDAQ: JAZZ) CEO donates 600 shares - Stock Titan

Jun 05, 2026
pulisher
Jun 05, 2026

Jazz Pharmaceuticals to Present Comprehensive Data at SLEEP 2026 Highlighting Broad Treatment Effects of Xywav Oral Solution for People with Narcolepsy and Idiopathic Hypersomnia - marketscreener.com

Jun 05, 2026
pulisher
Jun 05, 2026

Jazz Pharmaceuticals (NASDAQ:JAZZ) Flashes Perfect Minervini Trend Template Score with 116% Annual Surge - ChartMill

Jun 05, 2026
pulisher
Jun 05, 2026

Globeflex Capital L P Takes $780,000 Position in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Jun 05, 2026

Jazz Pharmaceuticals Plc (JAZZ) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Jazz Pharmaceuticals Plc (JAZZ) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Patil Neena M
EVP & Chief Legal Officer
Jun 10 '26
Sale
231.83
1,200
278,196
51,549
$30.41
price up icon 1.27%
$55.40
price up icon 6.27%
$89.50
price down icon 1.43%
$54.21
price down icon 0.11%
ONC ONC
$263.92
price down icon 1.60%
$156.58
price down icon 2.17%
大文字化:     |  ボリューム (24 時間):